Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carolin D. Strobl"'
Autor:
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, Carolin D. Strobl, Maximilian Muenchhoff, Clemens Scherer, Andreas Osterman, Michael Heide, Anna Reischer, Marion Subklewe, Alexandra Leutbecher, Benjamin Tast, Adrian Ruhle, Tobias Weiglein, Stephanie-Susanne Stecher, Hans J. Stemmler, Martin Dreyling, Philipp Girl, Enrico Georgi, Roman Wölfel, Laura Mateyka, Elvira D’Ippolito, Kilian Schober, Dirk H. Busch, Juliane Kager, Christoph D. Spinner, Matthias Treiber, Sebastian Rasch, Tobias Lahmer, Roman Iakoubov, Jochen Schneider, Ulrike Protzer, Christof Winter, Jürgen Ruland, Michael Quante, Oliver T. Keppler, Michael von Bergwelt-Baildon, Johannes Hellmuth, Oliver Weigert
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e603 (2021)
The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and c
Externí odkaz:
https://doaj.org/article/094ad305bd0d4e23983309dd91f61e83
Autor:
Tabea Haug, Michael Aigner, Moritz M. Peuser, Carolin D. Strobl, Kai Hildner, Dimitrios Mougiakakos, Heiko Bruns, Andreas Mackensen, Simon Völkl
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The recently discovered population of TCRαβ+ CD4–/CD8– (double-negative, DN) T-cells are highly potent suppressor cells in mice and humans. In preclinical transplantation models, adoptive transfer of DN T-cells specifically inhibits alloreactiv
Externí odkaz:
https://doaj.org/article/8b25ee21c15d44348bae1f697e642366
Autor:
Tabea Haug, Carolin D. Strobl, Martin Böttcher, Michael Aigner, Dimitrios Mougiakakos, Simon Völkl, Stefanie Schaffer, Andreas Mackensen, Katrin Singer, Katrin Peter
Publikováno v:
Molecular Cancer Therapeutics. 19:409-419
Genetic alterations in tumor cells provide promising targets for antitumor therapy. Recently, loss of methylthioadenosine phosphorylase (MTAP), a deletion frequently occurring in cancer, has been shown to create vulnerability to the inhibition of the
Autor:
Heiko Bruns, Dimitrios Mougiakakos, Moritz Peuser, Carolin D. Strobl, Kai Hildner, Simon Völkl, Tabea Haug, Michael Aigner, Andreas Mackensen
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology
The recently discovered population of TCRαβ+ CD4-/CD8- (double-negative, DN) T-cells are highly potent suppressor cells in mice and humans. In preclinical transplantation models, adoptive transfer of DN T-cells specifically inhibits alloreactive T-
Autor:
Frederik C. Henrich, Andreas Mackensen, Anita N. Kremer, Michael Aigner, Marina Kreutz, Katrin Peter, Carolin D. Strobl, Katrin Singer
Publikováno v:
Cancer Research. 77:3971-3971
Metabolic changes of malignant cells lead to the secretion of tumor metabolites which contribute to the shaping of a favorable milieu for tumor immune escape facilitating cancer development and resistance to anti-tumor immunotherapy. Recently, disrup
Autor:
Carolin D. Strobl, Marina Kreutz, Andreas Mackensen, Anja-Kathrin Bosserhoff, Frederik C. Henrich, Michael Aigner
Publikováno v:
Cancer Research. 76:5118-5118
Establishment of an immunosuppressive microenvironment is one mechanism of tumor immune escape. Elevated levels of 5’-deoxy-5’-methylthioadenosine (MTA) were detected in various tumor entities and spurred interest as putative immuno-inhibitory me
Autor:
Axel P. Ritter, Eva Gottfried, Michael Aigner, Frederik C. Henrich, Simon Völkl, Marina Kreutz, Luise Bernhardt, Carolin D. Strobl, Andreas Mackensen, Kerstin Poller, Peter J. Oefner, Dimitrios Mougiakakos, Anja-Katrin Bosserhoff, Katharina Limm, Katrin Peter, Katja Dettmer, Katrin Singer, Benedikt Jacobs
Publikováno v:
OncoImmunology. 5:e1184802
The immunosuppressive tumor microenvironment represents one of the main obstacles for immunotherapy of cancer. The tumor milieu is among others shaped by tumor metabolites such as 5′-deoxy-5′-methylthioadenosine (MTA). Increased intratumoral MTA